Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1336.HK Stock Summary
Top 10 Correlated ETFs
1336.HK
In the News
1336.HK Financial details
Company Rating
Sell
Market Cap
83.46B
Income
14.17B
Revenue
78.62B
Book val./share
35.25
Cash/share
5.53
Dividend
1.18
Dividend %
9.17%
Employees
32.56K
Optionable
No
Shortable
Yes
Earnings
27 Aug 2024
P/E
2.83
Forward P/E
2.72
PEG
-5.65
P/S
0.95
P/B
0.37
P/C
2.51
P/FCF
1.45
Quick Ratio
-
Current Ratio
-
Debt / Equity
0.1
LT Debt / Equity
0.1
-
-
EPS (TTM)
4.55
EPS next Y
5.09
EPS next Q
1.31
EPS this Y
-34.24%
EPS next Y
11.77%
EPS next 5Y
11.77%
EPS last 5Y
4.4%
Revenue last 5Y
6.87%
Revenue Q/Q
90.11%
EPS Q/Q
-114.29%
-
-
-
-
SMA20
-6.67%
SMA50
-
SMA100
-22.22%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
13%
ROC
0.02%
Gross Margin
100%
Oper. Margin
39%
Profit Margin
18%
Payout
27%
Shs Outstand
6.17B
Shs Float
5.07B
-
-
-
-
Target Price
-
52W Range
12.6-25.0
52W High
-44.56%
52W Low
+15.5%
RSI
39
Rel Volume
1.45
Avg Volume
5.45M
Volume
7.87M
Perf Week
-3.08%
Perf Month
-1.28%
Perf Quarter
-24.59%
Perf Half Y
-29%
-
-
-
-
Beta
0.851
-
-
Volatility
0.38%, 0.58%
Prev Close
2.06%
Price
13.86
Change
0.58%
1336.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 49.3 | 55.83 | 66.12 | 71.16 | 68.74 | |
Net income per share | 2.54 | 4.67 | 4.58 | 4.79 | 3.15 | |
Operating cash flow per share | 4.41 | 13.5 | 21.53 | 23.67 | 28.67 | |
Free cash flow per share | 1.91 | 11.89 | 20.56 | 22.63 | 28.09 | |
Cash per share | 99.36 | 128.01 | 140.95 | 134.28 | 126.12 | |
Book value per share | 21.03 | 27.09 | 32.59 | 34.78 | 33 | |
Tangible book value per share | 19.86 | 25.9 | 31.39 | 33.57 | 31.72 | |
Share holders equity per share | 21.03 | 27.09 | 32.59 | 34.78 | 33 | |
Interest debt per share | 1.28 | 0.31 | 3.55 | 3.54 | 3.48 | |
Market cap | 85.12B | 93.25B | 78.88B | 53.08B | 52.59B | |
Enterprise value | 80.17B | 82.45B | 76.95B | 48.65B | 45.86B | |
P/E ratio | 10.74 | 6.41 | 5.52 | 3.55 | 5.35 | |
Price to sales ratio | 0.55 | 0.54 | 0.38 | 0.24 | 0.25 | |
POCF ratio | 6.18 | 2.21 | 1.17 | 0.72 | 0.59 | |
PFCF ratio | 14.28 | 2.52 | 1.23 | 0.75 | 0.6 | |
P/B Ratio | 1.3 | 1.1 | 0.78 | 0.49 | 0.51 | |
PTB ratio | 1.3 | 1.1 | 0.78 | 0.49 | 0.51 | |
EV to sales | 0.52 | 0.47 | 0.37 | 0.22 | 0.21 | |
Enterprise value over EBITDA | 7.49 | 6.02 | 4.74 | 3.02 | 5.53 | |
EV to operating cash flow | 5.82 | 1.96 | 1.15 | 0.66 | 0.51 | |
EV to free cash flow | 13.45 | 2.22 | 1.2 | 0.69 | 0.52 | |
Earnings yield | 0.09 | 0.16 | 0.18 | 0.28 | 0.19 | |
Free cash flow yield | 0.07 | 0.4 | 0.81 | 1.33 | 1.67 | |
Debt to equity | 0.06 | 0.01 | 0.11 | 0.1 | 0.11 | |
Debt to assets | 0.01 | 0 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | -0.46 | -0.79 | -0.12 | -0.28 | -0.81 | |
Current ratio | 53.61 | 67.36 | 65.22 | 64.7 | 64.89 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.74 | 2.89 | 4.7 | 4.94 | 9.1 | |
Dividend Yield | 0.02 | 0.03 | 0.06 | 0.09 | 0.09 | |
Payout ratio | 0.23 | 0.17 | 0.31 | 0.31 | 0.49 | |
Sales general and administrative to revenue | 0.08 | 0.08 | 0.06 | 0.06 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.57 | -0.12 | -0.05 | -0.04 | -0.02 | |
Capex to revenue | -0.05 | -0.03 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -12.27 | -4 | -2 | -2.01 | -1 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 34.67 | 53.35 | 57.97 | 61.23 | 48.36 | |
ROIC | 0.11 | 0.16 | 0.12 | 0.11 | 0.09 | |
Return on tangible assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
Graham Net | -114.92 | -126.84 | -148.42 | -192.43 | -243.39 | |
Working capital | 304.11B | 393.14B | 432.96B | 412.43B | 387.18B | |
Tangible asset value | 61.93B | 80.74B | 97.93B | 104.72B | 98.9B | |
Net current asset value | -358.44B | -395.45B | -462.99B | -600.3B | -758.9B | |
Invested capital | 0.06 | 0.01 | 0.11 | 0.1 | 0.11 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 4.6B | 5.85B | 6.33B | 6.61B | 6.27B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.12 | 0.17 | 0.14 | 0.14 | 0.1 | |
Capex per share | -2.5 | -1.62 | -0.97 | -1.04 | -0.57 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 14.84 | 14 | 4.98 | 2.19 | 4.22 | |
Net income per share | 0 | 1.5 | 2.22 | 0.98 | -0.14 | |
Operating cash flow per share | 0 | 1.5 | 2.22 | 8.74 | 4.59 | |
Free cash flow per share | -0.09 | 1.37 | 2.07 | 8.6 | 4.47 | |
Cash per share | 128.37 | 127.14 | 6.73 | 5.96 | 5.53 | |
Book value per share | 32.01 | 33.26 | 39.03 | 35.99 | 35.25 | |
Tangible book value per share | 30.8 | 31.98 | 406.76 | 414.65 | 438.93 | |
Share holders equity per share | 32.01 | 33.26 | 39.03 | 35.99 | 35.25 | |
Interest debt per share | 3.49 | 3.51 | 9.94 | 8.54 | 7.85 | |
Market cap | 42.44B | 52.17B | 50.83B | 59.53B | 54.05B | |
Enterprise value | 40.43B | 45.44B | 41.04B | 51.79B | 47.98B | |
P/E ratio | 3.54K | 2.82 | 1.84 | 4.86 | -30.99 | |
Price to sales ratio | 0.91 | 1.2 | 3.27 | 8.73 | 4.17 | |
POCF ratio | 14.15K | 11.26 | 7.35 | 2.18 | 3.83 | |
PFCF ratio | -151.56 | 12.34 | 7.88 | 2.22 | 3.93 | |
P/B Ratio | 0.42 | 0.51 | 0.42 | 0.53 | 0.5 | |
PTB ratio | 0.42 | 0.51 | 0.42 | 0.53 | 0.5 | |
EV to sales | 0.87 | 1.05 | 2.64 | 7.6 | 3.7 | |
Enterprise value over EBITDA | -35.46 | 14.65 | 1.48 | 23.44 | -21.21 | |
EV to operating cash flow | 13.48K | 9.81 | 5.93 | 1.9 | 3.4 | |
EV to free cash flow | -144.39 | 10.74 | 6.36 | 1.93 | 3.49 | |
Earnings yield | 0 | 0.09 | 0.14 | 0.05 | -0.01 | |
Free cash flow yield | -0.01 | 0.08 | 0.13 | 0.45 | 0.25 | |
Debt to equity | 0.11 | 0.11 | 0.09 | 0.1 | 0.1 | |
Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Net debt to EBITDA | 1.76 | -2.17 | -0.35 | -3.5 | 2.69 | |
Current ratio | 62.03 | 64.89 | 3.52 | 2.7 | 2.85 | |
Interest coverage | 0 | 0 | 1.41 | 0.14 | -0.17 | |
Income quality | 1 | 1 | 1 | 8.91 | -32.35 | |
Dividend Yield | 0.1 | 0 | 0 | 0 | 0.06 | |
Payout ratio | 1.47K | 0 | 0.02 | 0.09 | -7.64 | |
Sales general and administrative to revenue | 0.06 | 0.07 | 0.05 | 0.13 | 0.06 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -94.33 | -0.09 | -0.07 | -0.02 | -0.03 | |
Capex to revenue | -0.01 | -0.01 | -0.03 | -0.06 | -0.03 | |
Capex to depreciation | 0.3 | -0.27 | 0 | -0.44 | 0.37 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.83 | 33.48 | 44.15 | 28.19 | 10.61 | |
ROIC | 0 | 0.04 | 0.18 | 0.02 | 0 | |
Return on tangible assets | 0 | 0 | 0.01 | 0 | 0 | |
Graham Net | -222.01 | -245.37 | 2.84 | 2.18 | 1.69 | |
Working capital | 394.75B | 387.18B | 15.02B | 11.71B | 11.05B | |
Tangible asset value | 96.28B | 98.9B | 1267.36B | 1293.51B | 1348.68B | |
Net current asset value | -693.92B | -758.9B | 8.85B | 6.79B | 5.19B | |
Invested capital | 0.11 | 0.11 | 0.09 | 0.1 | 0.1 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 6.45B | 6.26B | 3.03B | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0.05 | 0.06 | 0.03 | 0 | |
Capex per share | -0.09 | -0.13 | -0.15 | -0.14 | -0.12 |
1336.HK Frequently Asked Questions
What is New China Life Insurance Company Ltd. stock symbol ?
New China Life Insurance Company Ltd. is a CN stock and trading under the symbol 1336.HK
What is New China Life Insurance Company Ltd. stock quote today ?
New China Life Insurance Company Ltd. stock price is $13.86 today.
Is New China Life Insurance Company Ltd. stock public?
Yes, New China Life Insurance Company Ltd. is a publicly traded company.